339 related articles for article (PubMed ID: 24703457)
1. Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure.
Lundgren J; Rådegran G
Acta Physiol (Oxf); 2014 Jun; 211(2):314-33. PubMed ID: 24703457
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension associated with left heart disease.
Adir Y; Amir O
Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary hypertension and heart failure: the role of pulmonary vasculature].
Nallet O; Milleron O; Monsel F; Safar B; Ghrissi I; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):304-9. PubMed ID: 19819418
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in heart failure.
Guglin M; Khan H
J Card Fail; 2010 Jun; 16(6):461-74. PubMed ID: 20610227
[TBL] [Abstract][Full Text] [Related]
6. Current and future therapy for pulmonary hypertension in patients with right and left heart failure.
Abdelhady K; Gramling-Babb P; Awad S; Rebeiz AG; Salehi P; Chaudhry A; Diodato M; Rizkallah LE; Chedrawy EG; Prasad S; Massad MG
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):241-50. PubMed ID: 20136610
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension – a common condition in left heart disease].
Lundgren J; Rådegran G
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in chronic heart failure.
Bonderman D; Martischnig AM; Moertl D; Lang IM
Int J Clin Pract Suppl; 2009 Mar; (161):4-10. PubMed ID: 19178599
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.
Guazzi M; Labate V
Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232
[TBL] [Abstract][Full Text] [Related]
10. Management of pulmonary hypertension in left heart disease.
Schmeisser A; Schroetter H; Braun-Dulleaus RC
Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):131-51. PubMed ID: 23592742
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.
Thenappan T; Shah SJ; Gomberg-Maitland M; Collander B; Vallakati A; Shroff P; Rich S
Circ Heart Fail; 2011 May; 4(3):257-65. PubMed ID: 21411741
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in pulmonary arterial hypertension.
Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
Waxman AB; Zamanian RT
Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
[TBL] [Abstract][Full Text] [Related]
14. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary hypertension caused by left heart disease].
Erer B; Eren M
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():42-6. PubMed ID: 20819756
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history.
Segers VF; Brutsaert DL; De Keulenaer GW
Curr Opin Cardiol; 2012 May; 27(3):273-80. PubMed ID: 22327289
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension].
Lundgren J; Rådegran G
Lakartidningen; 2019 Mar; 116():. PubMed ID: 31192396
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacologic interventions--treating endothelial dysfunction and group 2 pulmonary hypertension.
Guazzi M; Gomberg-Maitland M; Naeije R
Prog Cardiovasc Dis; 2015; 57(5):473-9. PubMed ID: 25446553
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010].
Rosenkranz S; Bonderman D; Buerke M; Felgendreher R; ten Freyhaus H; Grünig E; de Haan F; Hammerstingl C; Harreuter A; Hohenforst-Schmidt W; Kindermann I; Kindermann M; Kleber FX; Kuckeland M; Kübler WM; Mertens D; Mitrovic V; Opitz C; Schmeisser A; Schulz U; Speich R; Zeh W; Weil J;
Dtsch Med Wochenschr; 2010 Oct; 135 Suppl 3():S102-14. PubMed ID: 20862619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
